‘Broken': Georgia woman who gave birth to someone else's baby sues fertility clinic
SAVANNAH, Ga. (WSAV) — A Georgia woman says her journey to motherhood has left her 'emotionally and physically broken,' and now she is suing the company responsible.
Even as a child, Krystena Murray, 38, of Savannah, always told people it was her dream to be a mom. Two years ago, she became pregnant after undergoing in vitro fertilization, a life-changing procedure for people trying to have a child.
She said her joy was taken away within seconds of delivery after discovering that the fertility clinic had made a fateful mistake. She is now suing Coastal Fertility Specialists for negligence.
Murray had turned to Coastal Fertility Specialists to help her get pregnant. She began treatment in early 2023 and became pregnant the second time an embryo was implanted in her uterus. She gave birth in December 2023, but within 15 seconds of the baby boy's arrival, her life had changed forever.
'He was beautiful and literally the best thing I had ever seen. But it was also immediately apparent that he was African-American,' said Murray, who, along with her sperm donor, is white.
Coastal Fertility Specialists sued over IVF mixup, custody suit
Murray said she later learned doctors had transferred another patient's embryo instead of her own. She filed a civil lawsuit Tuesday against Coastal Fertility Specialists, alleging the clinic's negligence caused her ongoing pain and anguish.
'The fertility clinic has hurt me in ways that I have yet to discover, and there are literally no words or unit of measure that can describe the damage that they have caused,' explains Murray.
The clinic had implanted the wrong embryo into Murray's body, meaning she gave birth to someone else's son.
'The baby she delivered was African-American. It was clear to Krystena that coastal fertility specialist had made an unimaginable error,' said Adam Wolf, Murray's attorney. 'A DNA test then confirmed that this is in fact what had occurred. Coastal fertility had transferred to Krystena an embryo that belonged to another couple.'
Murray knew immediately that the baby didn't develop from one of her own lab-fertilized eggs.
'My first thought is he's beautiful. My second thought was what happened?' said Murray. 'Did they mess up the embryo or did they mess up the sperm? And if they messed up the embryo, can someone take my son?'
That's exactly the situation she faced.
Knowing she was not the biological mother and would not win a legal battle, after caring and loving her son for five months, she gave him up to the couple whose egg she had carried.
'I obviously would have kept him forever if I could have, and I would have done anything to have done that,' said Murray. 'But that was not an option. So I did what was best for him and made that process as quick and easy as possible with the hopes that this would hopefully not affect him and his growth and development in the future, that he could go and bond with his new family and that this would not be something that would have lifelong effects on him.'
Murray said after reporting the mix-up to the fertility clinic, its staff tracked down and notified the baby's biological parents, who demanded custody.
'My child was ultimately taken from me as the clinic had implanted into my womb the embryo from a stranger. I have never felt so violated, and this situation has left me emotionally and physically broken,' said Murray.
'I'll never be the same woman. I will never fully heal or completely move on. And part of me will always long for my son and wonder what kind of person he's becoming.'
More adults are wondering if they have autism. Here are tips to seek a diagnosis
Her lawsuit says the clinic's 'extreme and outrageous' mistake caused Murray to be 'turned into an unwitting surrogate, against her will, for another couple.' She's seeking unspecified monetary damages.
'I can tell you that carrying a child who is not yours unknowingly and loving them, creating a whole life for them, birthing them, knowing they're not yours, loving them anyway, and wanting them. I honestly would have just chosen not to become a mother,' she said.
Wolf said while this situation is impossibly sad, Murray is far from alone.
'Coastal Fertility made a serious mistake and the consequences are life-altering for Krystena,' Wolf said. 'This is not the first IVF mixed-up case that I've handled, and sadly, it will not be the last. A big reason is the lack of regulation. Unfortunately, the United States is one of the few developed countries without meaningful oversight over fertility clinic laboratories. Until IVF clinics are subject to real regulations, reporting requirements and mandatory certification programs for lab staff these types of errors will continue to occur.'
Coastal Fertility Specialists operates a clinic in Savannah and four others in neighboring South Carolina. The medical practice apologized in an emailed statement for what it called 'an unprecedented error that resulted in an embryo transfer mix-up.' It said the staff has adopted new safeguards to prevent similar mistakes from happening in the future.
'This was an isolated event with no further patients affected,' the statement said. 'We are doing everything we can to make things right for those affected by this incident.'
The Associated Press contributed to this report.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Associated Press
22 minutes ago
- Associated Press
Catheter Precision (VTAK) Reports Key Progress for the LockeT Product
FORT MILL, S.C., June 12, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the cardiac electrophysiology market announced that LockeT sales for Q2 2025 are on track to be the highest to date. Second quarter 2025 LockeT sales are already outpacing Q2 2024 sales with a 200% increase. Catheter Precision now has several US hospitals that are on track to issue more than $100,000 in purchase orders each for LockeT by the end of 2025. These hospitals include Montefiore (Bronx, NY), Eisenhower Health (Rancho Mirage, CA), and Overland Park Regional Medical Center (Overland Park, KS). As previously announced, LockeT received the CE Mark enabling sales in Europe. Catheter Precision has secured a new distributor in Italy and anticipates additional distributors in the coming days for Spain, Portugal and the UK and is actively searching for the right partner is other EU countries. David Jenkins, CEO of Catheter Precision said, 'We are excited about the upcoming activities, sales pipeline and expanded use by existing customer to increase revenue generated by LockeT. At this time, there is a live case scheduled on Monday, Juen 16 with a key opinion leader where he will demonstrate LockeT during an Italian symposium, increasing its awareness to the new market. As a company, we continue to focus on improving product awareness, increasing product usage and expanding our footprint into Europe.' About LockeT Catheter Precision's LockeT is a suture retention device intended to assist in wound closure after percutaneous venous punctures. LockeT is a Class 1 device registered with the FDA and has received CE Mark approval. About Catheter Precision Catheter Precision is an innovative U.S.-based medical device company bringing new solutions to market to improve the treatment of cardiac arrhythmias. It is focused on developing groundbreaking technology for electrophysiology procedures by collaborating with physicians and continuously advancing its products. Cautionary Note Regarding Forward-Looking Statements Statements in this press release may contain 'forward-looking statements' within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to substantial risk and uncertainties. Forward-looking statements can be identified by words such as 'believe,' 'anticipate,' 'may,' 'might,' 'can,' 'could,' 'continue,' 'depends,' 'expect,' 'expand,' 'forecast,' 'intend,' 'predict,' 'plan,' 'rely,' 'should,' 'will,' 'may,' 'seek,' or the negative of these terms and other similar expressions, although not all forward-looking statements contain these words. These forward-looking statements include, but are not limited to, statements regarding product evaluations at the hospital, and that the purchase order indicates that the hospital and its staff see the value and benefits that LockeT can bring and expectations regarding LockeT evaluations in the coming weeks. The Company's expectations and beliefs regarding these matters may not materialize. Actual outcomes and results may differ materially from those contemplated by these forward-looking statements as a result of uncertainties, risks and changes in circumstances, including but not limited to risks and uncertainties included under the caption 'Risk Factors' in the Company's Form 10-K filed with the SEC and available at The forward-looking statements included in this communication are made only as of the date hereof. The Company assumes no obligation and does not intend to update these forward-looking statements, except as required by law. CONTACTS: At the Company David Jenkins 973-691-2000 [email protected] # # #
Yahoo
26 minutes ago
- Yahoo
Analysis-Kennedy's ouster of US vaccine advisers puts pharma ties under scrutiny
By Chad Terhune (Reuters) -U.S. Health Secretary Robert F. Kennedy Jr.'s surprise ouster of a national vaccine advisory board, claiming it was "plagued with persistent conflicts of interest," puts new scrutiny on the group that recommends which shots should be administered to the American public. Kennedy said most vaccine experts on the 17-member Advisory Committee on Immunization Practices (ACIP) have received "substantial funding" from drugmakers. He did not provide examples of conflicts of interest for any individual adviser or say how that may have influenced specific recommendations. Committee members say their work with the U.S. Centers for Disease Control and Prevention follows rigorous vetting of their financial ties. They must abstain from votes on any vaccine for which they have a conflict, as well as any rival to that vaccine or any product from the same manufacturer, according to CDC rules. The agency's website lists one of the departing panel members as recusing herself over such conflicts. "To determine that the whole (advisory board), all 17 members, have conflicts of interest, that has not been shown by the evidence," fired board member Dr. Oliver Brooks told Reuters. "However, the decisions that have been made (by Kennedy) undermine confidence in the process and in vaccines." Six of the vaccine advisers fired by Kennedy received a total of $80 or less from drugmakers from 2017 to 2023, according to a Reuters review of the Open Payments federal database of industry payments to healthcare providers. Seven other panel members received between $4,000 and $55,000 from drugmakers for consulting, speaking fees, travel or meals over the period 2017 to 2023. Two of those experts had also worked with other scientists in industry-funded research projects worth several millions of dollars. Brooks, retired chief medical officer at Watts Healthcare in Los Angeles and former president of the National Medical Association, received nearly $44,000 in general payments from Sanofi, according to the government records. Most of the payments occurred in 2017 and 2018, with nothing after 2020. Brooks became a vaccine adviser in 2021, and did not disclose any conflicts that would preclude him from voting. He said the panel's sole aim is "to prevent vaccine-preventable illness." Sanofi declined to comment. At least three vaccine advisers were not health professionals tracked by mandatory Open Payments reporting. KENNEDY'S CONFLICT Kennedy, who has spent years sowing doubts about vaccine safety and efficacy contrary to scientific evidence, faced questions from Congress about his own potential conflicts of interest during a confirmation hearing. Kennedy said he would divest his financial interest in litigation against Merck over its Gardasil vaccine, which prevents cancers caused by the human papillomavirus, to his non-dependent, adult son. In posts on X this week, Kennedy said he would share "examples of the historical corruption at ACIP" and announced eight new panel members. Four of them had received nominal reimbursement for meals, according to Open Payments, while the remainder recorded no payments or weren't covered by the database. A 2009 federal inspector general's report criticized the CDC for lax enforcement of disclosures among its advisory panels. New research shared with Reuters suggests conflicts have since declined among vaccine board members. "People are more aware of these issues on advisory committees, so they're facing greater scrutiny there," said Dr. Genevieve Kanter, an associate professor of public policy at the University of Southern California who has studied conflicts among government health advisers. Kanter's analysis of vaccine panel disclosures found that, on average, 43% of panel members facing decisions on specific vaccines declared conflicts in 2000 compared to 5%, on average, at meetings over the last 10 years. Kanter said it will also be important to understand how the vaccine advisers assembled by Kennedy are vetted for conflicts. They are due to meet at the end of June. "We don't want to replace one conflict with another set of conflicts," she said. "If someone has a financial interest in treatments that are believed to be alternatives to vaccines for certain conditions, we want to know that." DISCLOSURE RULES ACIP members are required to divest all stock in vaccine makers and stop any active consulting work for those companies before joining the panel. They can't accept travel or food from vaccine companies or collect product royalties. Similar restrictions apply to family members. Committee members can keep working on vaccine clinical trials funded by industry and those research grants can help cover their salaries. They are required to file annual disclosures and recuse themselves from votes when specific conflicts arise. "ACIP members ... are carefully screened for major conflicts of interest and selected through a lengthy process," said the California Department of Public Health, whose immunization chief, Dr. Robert Schechter, was fired from the panel by Kennedy. One of the fired panel members, Dr. Bonnie Maldonado, is a pediatric infectious diseases specialist at Stanford University who has led vaccine studies worldwide. She participated in research that received $4.65 million in funding from Pfizer, most of it spanning 2021 to 2023. The studies involved vaccines for COVID-19, RSV and other diseases. Maldonado also received general payments from drugmakers, including $26,465 from Pfizer and nearly $7,000 from Merck. Maldonado abstained from a vote on COVID vaccine recommendations in June 2024, declaring a conflict of interest. In October, she did participate in a COVID-related vote. Maldonado didn't respond to a request for comment. Noel Brewer, a professor of public health at the University of North Carolina, is not a clinician and therefore not included in Open Payments. In a 2017 research paper, he disclosed receiving research grants from Merck, Pfizer and GSK and serving on a paid advisory board for Merck. The disclosures did not give details on the payment amounts. Spokespeople for the three vaccine makers were not immediately available for comment.
Yahoo
an hour ago
- Yahoo
Goodbye, dad bod: Weight loss medications are changing fathers' physiques — and their relationships with their kids.
Neal Bland has done Ironman competitions and marathons. He's given countless personal training sessions over the course of his life and has always prided himself on staying in shape, especially given that obesity runs in his family. But by age 52, time and genetics had begun to catch up with Bland (who asked that we not use his real last name for privacy reasons). His blood pressure and blood sugar were climbing, his body mass index was hovering in the low 30s, and his joints were aching. Then, during a photo shoot with his wife last year, the photographer told Bland he 'looked good for a dad bod.' Bland knew the photographer had 'meant it as a compliment,' he tells Yahoo Life, 'but it really stuck.' He was still maintaining a rigorous diet and exercise regimen at the time, but it wasn't working for him. So, in March of 2024, he started on the GLP-1 medication tirzepatide. He's lost 45 pounds in a phase of his life he's dubbed his 'dad bod reboot.' Let's be clear: There's nothing wrong with a dad bod. In fact, the expectation for men to have chiseled abs — at any point, but especially in middle and older age — can be harmful. But for the 38% of American dads who are obese, their bodies may be putting them at risk of type 2 diabetes, heart disease and other potentially life-threatening medical conditions. Some of these fathers have started taking GLP-1 weight loss medications, a decision that can bring about not just changes to their 'bods' and health indicators, but also to their lives as parents. We spoke to some of them about what it's like to be a dad, minus their former bods. Thirty-seven-year-old father of two Noah Wiggins is taking his nursing board exams and looking forward to beginning his new career in health care. 'But I looked in the mirror and thought, I can't expect patients to be healthy and maintain a healthy weight if I can't,' he tells Yahoo Life. Plus, Wiggins loves coaching his children's sports teams, but he found himself getting winded and sore when he tried to demonstrate athletic skills for the kids. While he could shed pounds for a time with the help of various diets, he couldn't maintain a healthy weight long-term. So Wiggins talked to his own health care provider, who agreed that GLP-1 medication could be a good option for him. He started taking Zepbound in January 2024. The medication, along with the support of his two children, has helped him lose more than 80 pounds since then. 'As I started to lose weight and get more active, they started making comments and encouraging me to make healthy food choices … without judgment,' says Wiggins. His daughter, who is about to turn 16, has been especially vocal, keeping Wiggins accountable when he picks up an unhealthy snack or tries to flake on going to the gym. 'I've had to fight the urge to say, 'I'm the parent, I'll go when I want to,'' says Wiggins. But ultimately, he's grateful for the tough-loving support from his kids. 'I think it's been a growing moment for them and for me,' he says. Wiggins's children have also noticed that he has more energy and can just be more fully present for them. Despite his progress, Wiggins still struggles with his body image. Like others that Wiggins has spoken to within the GLP-1 community, he half-expected that once the scale reached a certain number, he would feel satisfied with his body and appearance. 'But I don't know anyone who actually hits that number and feels like that,' he says. 'I look in the mirror and am happy with how I look and especially how I feel, but body dysmorphia is a real thing, and a lot of times you don't know you have it until you've lost weight.' At his lowest weight, Wiggins was tempted to lose another 20 pounds to make his reflection match the idealized version of himself in his mind, but he knew that would have put him below a healthy weight. That's when Wiggins realized that it wasn't about losing more weight. He needed to make a conscious effort to improve his mental health and confidence to help him feel content in his own skin. It's an important lesson that he wants his children to learn: how to 'be comfortable in your body, but balance that with good health,' Wiggins says. He's pushed himself to talk more openly with his kids about his own journey toward striking that balance. 'The best thing to do was just have more conversations with them about all of that, and they'll actually take the lead on those conversations once you start them.' Twenty years ago, when Ryan Rasmussen and his wife, AnnaLyn, were young newlyweds, they wanted desperately to start a family. After three years of trying, AnnaLyn got pregnant with quadruplets. But tragedy struck: None of the four babies survived more than about an hour after birth. The Rasmussens managed to pick up the pieces of their shattered hearts and eventually went on to have four children, born individually. But even as someone moves on, grief can linger in the body, wreaking havoc. For Rasmussen, the loss of his newborns quietly ate at him and, in turn, Rasmussen now recognizes he ate to cope with his grief. He reached nearly 300 pounds, he told Yahoo Life for our series On My Weigh. For those intervening 20 years, Rasmussen tried the Atkins diet and various other low-carb eating plans. He'd lose a little weight, then gain back as much or more. In the meantime, his family stayed active and went on ski trips. 'Annalyn is a marathon runner, and she's kept [the kids] in shape, but I think they've probably worried about me,' says Rasmussen. He tried to join their athletic activities, but skiing and hiking were hard on his overburdened joints. Two of his sisters, who also struggled with their weight, found success with GLP-1 medications. Impressed with their progress, Rasmussen tried the new class of weight loss drugs too. Within a year, he dropped 80 pounds. 'Being there for my family was the goal,' he says. Not only can Rasmussen now join the family ski trips, but hiking and spending time outdoors are day-to-day ways he bonds with his kids. His weight loss 'has definitely allowed us as a family to do more healthy activities,' Rasmussen says. Plus, his good habits have rubbed off on his children. Desserts, once a staple, are reserved for special occasions, and the household's midnight snacking has all but disappeared. Rasmussen's new body has also allowed him to get back in touch with his fashion sense. 'I like to look good and dress well, but when you're big, [that's] difficult,' he says. Now that he's lost weight, 'being able to dress with purpose in the morning has probably been one of the best things for me and my mental health,' says Rasmussen. And he's not the only one who's noticed his new look. One of his daughter's friends used the viral 'hear me out' cake trend on TikTok as an excuse to show some appreciation for Rasmussen. 'She said, 'hear me out, but Charlie's dad is attractive,'' Rasmussen explains. 'But [Charlie] was a good sport, she laughed about it.' Bland's now adult children grew up knowing him as the ultra-fit dad, who was always on the go for his job as a pharmaceutical researcher, or hitting the gym to train for his next big event. But he was always fighting against his genetics. 'I come from a long line of fluffy people,' Bland says. He spent his own childhood watching his mother constantly watch her weight. Despite avoiding smoking and drinking and maintaining a reasonably healthy diet, she eventually had to have both of her knees and one hip replaced and also suffered a stroke, 'all of which can be attributed to [extra] weight on your frame,' says Bland. Recognizing his family's propensity to obesity was part of what drove Bland to be so disciplined. 'But my genetics eventually outran my lifestyle,' he says. Even with the same routines in place, Bland gained weight in his early 50s, saw his A1C and blood pressure rise, and had inflammation in his hips and knees. And Bland admits that vanity was also a factor. The shirtless man in his vacation photos no longer looked like the version of himself he expected to see. 'I gained about 35 pounds in 10 years; it was the classic 'man-o-pause,'' he says. Though he didn't meet the clinical qualifications for brand-name GLP-1 medications, Bland tried compounded tirzepatide, suspecting that it would not only help him keep weight off but also reduce the inflammation in his joints. Once he started the medication, 'it was literally like somebody flipped a switch,' says Bland. The food noise (constant, intrusive thoughts about food) disappeared. He no longer ate just because he was bored. The joint pain was barely noticeable, and his workout recovery time improved. He also started to look more like himself in gym selfies. Bland didn't initially tell his children that he was taking GLP-1 medications. But one of his adult sons noticed that Bland was looking pretty shredded in some of his photos; in fact, he was a bit concerned. He told his father, 'You've lost so much weight and went from really fluffy to really not. Are you sure you're not ... taking PEDs,' meaning performance-enhancing drugs, recalls Bland. Though Bland, now 53, has been taking testosterone replacement therapy for years, that and the GLP-1 have allowed him to return to the weight and energy levels of his younger years. And he's now switched to a very low maintenance dose of tirzepatide to make sure he doesn't lose too much weight. 'It's been a little bit of a return to what they were used to when they were kids,' he says of his new — or, maybe more accurately, restored — bod. 'And I feel like I'm back to the person that my wife married,' Bland adds.